Hexaware will diversify its global delivery: R Srikrishna

Interview with Chief Executive, Hexaware Technologies

Hexaware Technologies, a mid-sized information technology and business process outsourcing company, on Monday appointed R Srikrishna as its chief executive. In an interview with Aditi Divekar, Srikrishna, former president of the infrastructure and life sciences businesses at larger rival HCL Technologies, talks about his plans for the company. Edited excerpt:

What is your focus?

Apart from the recent launch of a new vertical in the manufacturing sector, a few other verticals like are pharmaceuticals and railways need attention. I am a big believer in Europe and I think there is a lot of untapped opportunity in this region. In Asia Pacific too opportunities are untapped. Some of these investment decisions will be taken over the next  90 days.

What is your take on the SMAC (social, mobility, analytics, cloud) business?

SMAC is a narrow view as it does not include the internet of things and also the security aspect. It is an opportunity for the entire industry, but a great opportunity for Hexaware. To get value from SMAC, you first need to get your data right. Hexaware has a strong presence here. We will build by making more investments.

What is your plan to improve margins and the revenue stream?

We are focusing on consistent delivery of innovative services, making Hexaware a great place to work, and smart investments.

Last year, Hexaware opened two new global delivery centres in the US. Do you see the need for more?

Hexaware will have seamless global delivery centres. Global customers are worried about data privacy and access to data apart from factors like language, time zone and culture. These will necessitate Hexaware to continue to diversify its delivery.

What is your plan for the life sciences business at Hexaware?

The change that technology can bring to the healthcare segment is massive. Hexaware is already present in healthcare outsourcing, which will be the fastest growing service in the healthcare industry. This is a major opportunity.